Avanza Fonder’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$78.9M Buy
297,973
+33,158
+13% +$8.75M 1.51% 12
2026
Q2
$67.3M Buy
264,815
+4,880
+2% +$1.14M 1.46% 12
2026
Q1
$63.5M Buy
259,935
+874
+0.3% +$204K 1.76% 10
2025
Q4
$53.6M Buy
259,061
+8,940
+4% +$1.77M 1.36% 10
2025
Q3
$46.4M Buy
250,121
+15,474
+7% +$2.65M 1.2% 9
2025
Q2
$35.8M Buy
234,647
+6,566
+3% +$1.01M 1.06% 13
2025
Q1
$35.4M Sell
228,081
-30,668
-12% -$4.8M 1.16% 14
2024
Q4
$37.4M Buy
+258,749
New +$40.1M 1.11% 14

Other funds holding JNJ

Avanza Fonder's JNJ Position: Q3 2026 in Review

Avanza Fonder increased its Johnson & Johnson (JNJ) stake by 13% in Q3 2026, buying an estimated $8.75M and bringing the position to 297,973 shares worth $78.9M. The position accounts for 1.51% of the portfolio, ranked #12.

Avanza Fonder first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,734 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Avanza Fonder held 297,973 shares of Johnson & Johnson worth $78.9M as of Q3 2026.
  • Avanza Fonder bought 33,158 Johnson & Johnson shares in Q3 2026, an estimated $8.75M.
  • Johnson & Johnson made up 1.51% of Avanza Fonder's portfolio in Q3 2026, its #12 holding.
  • Avanza Fonder first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,734 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.